Ratings by Craig-Hallum (Matthew G. Hewitt)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/7/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2025 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2025 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 5/7/2025 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 2/25/2025 | HealthStream | HSTM | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2024 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 7/9/2024 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2024 | Apyx Medical Corp. | APYX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/9/2024 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2023 | Apyx Medical Corp. | APYX | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2023 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 11/1/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Surgalign Holdings Inc | SRGA | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2022 | Apyx Medical Corp. | APYX | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2022 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2022 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2022 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 2/23/2022 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 1/6/2022 | Vocera Communications | VCRA | Downgrade | Hold (Buy) |
62.52 (79.13) |
26.57% | Details | |
| 11/10/2021 | Surgalign Holdings Inc | SRGA | Maintain | Hold (N/A) |
|
Details | ||
| 11/2/2021 | Omnicell | OMCL | Maintain | Buy (N/A) |
|
Details | ||
| 10/28/2021 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 9/27/2021 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 8/12/2021 | Apyx Medical Corp. | APYX | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2021 | HealthStream | HSTM | Maintain | Buy (N/A) |
|
Details | ||
| 4/29/2021 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 2/25/2021 | Teladoc | TDOC | Maintain | Hold (N/A) |
|
Details | ||
| 2/24/2021 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 2/3/2021 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 1/20/2021 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 11/6/2020 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 10/27/2020 | HealthStream | HSTM | Maintain | Buy (N/A) |
|
Details | ||
| 10/21/2020 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details | ||
| 7/30/2020 | Repligen | RGEN | Maintain | Buy (N/A) |
|
Details | ||
| 4/28/2020 | HealthStream | HSTM | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2018 | Ligand Pharma | LGND | Maintain | Buy (N/A) |
|
Details |
